02:51 PM EDT, 08/07/2024 (MT Newswires) -- Emil D Kakkis, Director, President & CEO, on August 06, 2024, sold 20,000 shares in Ultragenyx Pharmaceutical ( RARE ) for $1,003,400. Following the Form 4 filing with the SEC, Kakkis has control over a total of 2,808,582 shares of the company, with 564,597 shares held directly and 2,243,985 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1515673/000095017024092608/xslF345X03/ownership.xml

Price: 48.70, Change: -1.07, Percent Change: -2.14